Shared decision support for blood thinners in atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests whether extra shared decision-making support can help people choose the right blood thinner and reduce racial differences in anticoagulation treatment. It focuses on adults with atrial fibrillation who are starting an oral blood thinner for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older
- You are Black or White
- You have a diagnosis of nonvalvular atrial fibrillation (a heart rhythm problem not caused by heart valve disease)
- You are starting an oral blood thinner (taken by mouth) at a new patient visit in primary care or cardiology
- Your stroke-risk score (CHA2DS2-VASc) is 2 or higher
- You can speak English and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a web-based decision aid that helps people with atrial fibrillation (AF) decide about stroke-prevention treatment, such as blood thinners. It may help you feel more confident and make safer choices by showing options at the right time after diagnosis.
This study tests an electronic decision-support tool used in the emergency department (ED) to help clinicians choose the safest way to prevent stroke when atrial fibrillation is newly found. It may help by improving how quickly and consistently stroke-prevention treatment is considered.
This study tests whether continuous heart-rhythm monitoring with a smartwatch can better guide treatment for atrial fibrillation (AF) while you stay on a blood thinner. The goal is to improve safety and reduce stroke risk by catching AF patterns more closely.
This study tests whether a computer program can help doctors decide when to prescribe blood thinners to people with atrial fibrillation who are at risk for stroke. If you have atrial fibrillation and are not on a blood thinner, you may be eligible.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This study tests whether a storytelling program can help African American patients with atrial fibrillation start taking blood thinners as recommended by their doctor. The goal is to reduce stroke risk and improve health outcomes.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.